Topics
Glioblastoma | Prognosis | Overall survival
Home > Publications > Topics > Glioblastoma > Prognosis > Overall survival
Gendreau
J, Mehkri Y, Kuo C, Chakravarti S, Jimenez MA, Shalom M, Kazemi F,
Mukherjee D.
Clinical
Predictors of Overall Survival in Very Elderly Patients With
Glioblastoma: A National Cancer Database Multivariable Analysis.
Neurosurgery.
2024 Jun 28. doi:
10.1227/neu.0000000000003072. PMID:
38940573. Observational study˰ ˍ
Habibi MA, Ghorbani M, Esmaeilian S, Tajvidi F, Nekutalaban P,
Boskabadi AR, Alemi F, Zafari R, Mirjani MS, Eazi S, Minaee P.
Stereotactic radiosurgery versus
combined stereotactic radiosurgery and bevacizumab for recurrent
glioblastoma; a systematic review and meta-analysis of survival.
Neurosurg
Rev. 2024 Jul 13;47(1):323. doi:
10.1007/s10143-024-02585-9. PMID:
39002028. Review; Meta-analysis˰
ˍ
*Harter PN, Weber KJ, Ricklefs FL, Drexler R, Schüller U,
Hack M, Hanke T, Dohmen H, Acker T, von Deimling A, Hasselblatt M,
Divé I, Unger K, Steinbach JP, Capper D, Ronellenfitsch MW.
Survival probability of epigenetically
defined IDH-wild-type glioblastoma without necrosis or vascular
proliferation.
Neurooncol
Adv. 2024 Aug 2;6(1):vdae138. doi:
10.1093/noajnl/vdae138. PMID:
39184173. Observational study. ˍ
Snider S, De Domenico P, Roncelli F, Bisoglio A, Braga M, Ghelfi
A, Barzaghi LR, Mura C, Mortini P, Gagliardi F.
Pre-operative
mean platelet volume is associated with overall survival in
patients with IDH-wildtype glioblastoma undergoing maximal safe
resection.
Oncol
Lett. 2024 Sep 30;28(6):576. doi:
10.3892/ol.2024.14709. PMID:
39397801. Observational study. ˍ
Alirezaei Z, Amouheidari A, BasirianJahromi R, Seyyedhosseini S,
Hamidi A.
Survival Analysis of
Glioblastoma: A Scientometric Perspective.
World
Neurosurg. 2024 Nov 20:S1878-8750(24)01919-3? doi:
10.1016/j.wneu.2024.11.059? PMID:
39577630. Bibliometric analysis˰
ˍ